Mount Sinai Ends Pediatric Sex-Change Care, Pays DOJ $2 Million
The deal, closing a probe into fraudulent billing tied to Trump's January 2025 directive, includes no finding of liability or guilt.
- Mount Sinai halts puberty blockers, cross-sex hormones and surgeries for minors under the deal.
- The $2 million funds care for people harmed by the treatments they received as children.
- Assistant Attorney General Brett Shumate's Civil Division built the case on false diagnosis codes.
Why it matters: Denying wrongdoing while paying to end the practice and fund its victims is itself a verdict.
DOJ Office of Public Affairs press release ↗ · Sep 7, 20269/7/26